軟式隱形眼鏡的開發平台 - 開發階段，市場區隔，地區和國家，法規途徑，主要企業(2024年版)

Soft Contact Lenses Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

出版日期: 2024年06月13日 | 出版商:

GlobalData | 英文 75 Pages | 訂單完成後即時交付

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

本報告提供軟式隱形眼鏡的開發中產品調查分析，提供涵括各種處於開發階段產品的比較分析，及進行中的臨床試驗等全面性資訊。

Alcon Inc:企業概要
- Alcon Inc:開發中產品和進行中的臨床試驗概要
Alcon Laboratories Inc:企業概要
- Alcon Laboratories Inc:開發中產品和進行中的臨床試驗概要
Bausch & Lomb Inc:企業概要
- Bausch & Lomb Inc:開發中產品和進行中的臨床試驗概要
BVS Sight Inc:企業概要
- BVS Sight Inc:開發中產品和進行中的臨床試驗概要
Clerio Vision Inc:企業概要
- Clerio Vision Inc:開發中產品和進行中的臨床試驗概要
Fitlens Ltd:企業概要
- Fitlens Ltd:開發中產品和進行中的臨床試驗概要
Imperial College London:企業概要
- Imperial College London:開發中產品和進行中的臨床試驗概要
Industrial Science & Technology Network Inc:企業概要
- Industrial Science & Technology Network Inc:開發中產品和進行中的臨床試驗概要
Johnson & Johnson Vision Care Inc:企業概要
- Johnson & Johnson Vision Care Inc:開發中產品和進行中的臨床試驗概要
Lentechs LLC:企業概要
- Lentechs LLC:開發中產品和進行中的臨床試驗概要
Lipocoat BV:企業概要
- Lipocoat BV:開發中產品和進行中的臨床試驗概要
Ocutec Ltd:企業概要
- Ocutec Ltd:開發中產品和進行中的臨床試驗概要
Purdue University:企業概要
- Purdue University:開發中產品和進行中的臨床試驗概要
Queen's University:企業概要
- Queen's University:開發中產品和進行中的臨床試驗概要
Smartlens Inc:企業概要
- Smartlens Inc:開發中產品和進行中的臨床試驗概要
Visioneering Technologies Inc:企業概要
- Visioneering Technologies Inc:開發中產品和進行中的臨床試驗概要
VISTAKON Pharmaceuticals LLC:企業概要
- VISTAKON Pharmaceuticals LLC:開發中產品和進行中的臨床試驗概要

第6章軟式隱形眼鏡 - 近幾年的發展

第7章附錄

簡介目錄

Product Code: GDME1762EPD

GlobalData's Medical Devices sector report, "Soft Contact Lenses Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Soft Contact Lenses pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Soft contact lenses are corrective gel-like lenses that conform to the shape of the eye.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Soft Contact Lenses under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Soft Contact Lenses and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Soft Contact Lenses under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Soft Contact Lenses Overview

3 Products under Development

3.1 Soft Contact Lenses - Pipeline Products by Stage of Development
3.2 Soft Contact Lenses - Pipeline Products by Territory
3.3 Soft Contact Lenses - Pipeline Products by Regulatory Path
3.4 Soft Contact Lenses - Pipeline Products by Estimated Approval Date
3.5 Soft Contact Lenses - Ongoing Clinical Trials

4 Soft Contact Lenses - Pipeline Products under Development by Companies

4.1 Soft Contact Lenses Companies - Pipeline Products by Stage of Development
4.2 Soft Contact Lenses - Pipeline Products by Stage of Development

5 Soft Contact Lenses Companies and Product Overview

5.1 Alcon Inc Company Overview
- 5.1.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Alcon Laboratories Inc Company Overview
- 5.2.1 Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Bausch & Lomb Inc Company Overview
- 5.3.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 BVS Sight Inc Company Overview
- 5.4.1 BVS Sight Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Clerio Vision Inc Company Overview
- 5.5.1 Clerio Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Fitlens Ltd Company Overview
- 5.6.1 Fitlens Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.7 Imperial College London Company Overview
- 5.7.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.8 Industrial Science & Technology Network Inc Company Overview
- 5.8.1 Industrial Science & Technology Network Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Johnson & Johnson Vision Care Inc Company Overview
- 5.9.1 Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Lentechs LLC Company Overview
- 5.10.1 Lentechs LLC Pipeline Products & Ongoing Clinical Trials Overview
5.11 Lipocoat BV Company Overview
- 5.11.1 Lipocoat BV Pipeline Products & Ongoing Clinical Trials Overview
5.12 Ocutec Ltd Company Overview
- 5.12.1 Ocutec Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 Purdue University Company Overview
- 5.13.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview
5.14 Queen's University Company Overview
- 5.14.1 Queen's University Pipeline Products & Ongoing Clinical Trials Overview
5.15 Smartlens Inc Company Overview
- 5.15.1 Smartlens Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Visioneering Technologies Inc Company Overview
- 5.16.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 VISTAKON Pharmaceuticals LLC Company Overview
- 5.17.1 VISTAKON Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview